Effect of a US National Institutes of Health programme of clinical trials on public health and costs
- 28 April 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 367 (9519) , 1319-1327
- https://doi.org/10.1016/s0140-6736(06)68578-4
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS 02254)
- National Institutes of Health (NS 02254)
This publication has 53 references indexed in Scilit:
- Payback arising from research funding: evaluation of the Arthritis Research CampaignRheumatology, 2005
- Acute Stroke Care in the USStroke, 2005
- Revisiting the Appropriateness of Carotid EndarterectomyStroke, 2003
- The underutilization of cardiacmedications of proven benefit, 1990 to 2002Journal of the American College of Cardiology, 2002
- A Randomized Trial of Tirilazad Mesylate in Patients With Acute Stroke (RANTTAS)Stroke, 1996
- A RANDOMIZED CLINICAL TRIAL OF ESCALATING DOSES OF HIGH DOSE EPINEPHRINE DURING CARDIAC RESUSCITATION.Critical Care Medicine, 1995
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990
- Randomized Clinical Study of Thiopental Loading in Comatose Survivors of Cardiac ArrestNew England Journal of Medicine, 1986
- Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic StrokeNew England Journal of Medicine, 1985